Erythropoietin-induced glioma and cervical cancer cells treated with tyrphostin B42, an inhibitor of JAK2 tyrosine kinase activity. JAK2 is an effector of EPOR.EPOR knockdown in GBM. This evidence concerns the gene JAK2 and cervical cancer.